{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:22:36Z","timestamp":1793316156840,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T00:00:00Z","timestamp":1696204800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T00:00:00Z","timestamp":1696204800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurocrit Care"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s12028-023-01859-2","type":"journal-article","created":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T22:01:26Z","timestamp":1696284086000},"page":"984-995","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["A Comparison of Ketamine and Midazolam as First-Line Anesthetic Infusions for Pediatric Status Epilepticus"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9489-6594","authenticated-orcid":false,"given":"Marin","family":"Jacobwitz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlyn","family":"Mulvihill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"Kaufman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander K.","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla","family":"Resendiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conall","family":"Francoeur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingo","family":"Helbig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis A.","family":"Topjian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas S.","family":"Abend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,2]]},"reference":[{"issue":"11","key":"1859_CR1","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1097\/PCC.0000000000003043","volume":"23","author":"ZS Daniels","year":"2022","unstructured":"Daniels ZS, Srdanovic N, Rychlik K, Smith C, Goldstein J, George AL. High-dose midazolam for pediatric refractory status epilepticus: a single-center retrospective study. Pediatr Crit Care Med. 2022;23(11):929\u201335. https:\/\/doi.org\/10.1097\/PCC.0000000000003043.","journal-title":"Pediatr Crit Care Med"},{"key":"1859_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.seizure.2017.02.015","volume":"47","author":"G Zaccara","year":"2017","unstructured":"Zaccara G, Giannasi G, Oggioni R, Rosati E. Challenges in the treatment of convulsive status epilepticus. Seizure. 2017;47:17\u201324. https:\/\/doi.org\/10.1016\/j.seizure.2017.02.015.","journal-title":"Seizure"},{"issue":"4","key":"1859_CR3","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1111\/epi.14016","volume":"59","author":"LJ Hirsch","year":"2018","unstructured":"Hirsch LJ, Gaspard N, van Baalen A, et al. Proposed consensus definitions for new-onset refractory status epilepticus (NORSE), febrile infection-related epilepsy syndrome (FIRES), and related conditions. Epilepsia. 2018;59(4):739\u201344. https:\/\/doi.org\/10.1111\/epi.14016.","journal-title":"Epilepsia"},{"issue":"5","key":"1859_CR4","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1177\/1535759720928269","volume":"20","author":"DG Vossler","year":"2020","unstructured":"Vossler DG, Bainbridge JL, Boggs JG, et al. Treatment of refractory convulsive status epilepticus: a comprehensive review by the American Epilepsy Society Treatments Committee. Epilepsy Curr. 2020;20(5):245\u201364. https:\/\/doi.org\/10.1177\/1535759720928269.","journal-title":"Epilepsy Curr"},{"issue":"6","key":"1859_CR5","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.pediatrneurol.2008.01.001","volume":"38","author":"NA Abend","year":"2008","unstructured":"Abend NA, Dlugos DJ. Treatment of refractory status epilepticus: literature review and a proposed protocol. Pediatr Neurol. 2008;38(6):377\u201390.","journal-title":"Pediatr Neurol"},{"issue":"75","key":"1859_CR6","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.seizure.2019.09.011","volume":"2020","author":"L Prisco","year":"2019","unstructured":"Prisco L, Ganau M, Aurangzeb S, et al. A pragmatic approach to intravenous anaesthetics and electroencephalographic endpoints for the treatment of refractory and super-refractory status epilepticus in critical care. Seizure. 2019;2020(75):153\u201364. https:\/\/doi.org\/10.1016\/j.seizure.2019.09.011.","journal-title":"Seizure"},{"issue":"7","key":"1859_CR7","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1097\/PCC.0000000000000173","volume":"15","author":"R Wilkes","year":"2014","unstructured":"Wilkes R, Tasker RC. Intensive care treatment of uncontrolled status epilepticus in children: systematic literature search of midazolam and anesthetic therapies. Pediatr Crit Care Med. 2014;15(7):632\u20139. https:\/\/doi.org\/10.1097\/PCC.0000000000000173.","journal-title":"Pediatr Crit Care Med"},{"issue":"10","key":"1859_CR8","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1097\/PCC.0000000000000900.Refractory","volume":"17","author":"RC Tasker","year":"2016","unstructured":"Tasker RC, Goodkin HP, Fernandez IS, et al. Refractory status epilepticus in children: intention-to-treat with continuous infusions of midazolam and pentobarbital. Pediatr Crit Care Med. 2016;17(10):968\u201375. https:\/\/doi.org\/10.1097\/PCC.0000000000000900.Refractory.","journal-title":"Pediatr Crit Care Med"},{"issue":"12","key":"1859_CR9","doi-asserted-by":"publisher","first-page":"e613","DOI":"10.1097\/pcc.0000000000002786","volume":"22","author":"A Vasquez","year":"2021","unstructured":"Vasquez A, Farias-Moeller R, S\u00e1nchez-Fern\u00e1ndez I, et al. Super-refractory status epilepticus in children: a retrospective cohort study. Pediatr Crit Care Med. 2021;22(12):e613\u201325. https:\/\/doi.org\/10.1097\/pcc.0000000000002786.","journal-title":"Pediatr Crit Care Med"},{"issue":"6","key":"1859_CR10","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1097\/MOP.0000000000000149","volume":"26","author":"RC Tasker","year":"2014","unstructured":"Tasker RC, Vitali SH. Continuous infusion, general anesthesia and other intensive care treatment for uncontrolled status epilepticus. Curr Opin Pediatr. 2014;26(6):682\u20139. https:\/\/doi.org\/10.1097\/MOP.0000000000000149.","journal-title":"Curr Opin Pediatr"},{"issue":"7","key":"1859_CR11","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1177\/0883073817698629","volume":"32","author":"S Keros","year":"2017","unstructured":"Keros S, Buraniqi E, Alex B, et al. Increasing ketamine use for refractory status epilepticus in US pediatric hospitals. J Child Neurol. 2017;32(7):638\u201346. https:\/\/doi.org\/10.1177\/0883073817698629.","journal-title":"J Child Neurol"},{"issue":"6","key":"1859_CR12","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1016\/j.clinph.2016.03.005","volume":"127","author":"O Akeju","year":"2016","unstructured":"Akeju O, Song AH, Hamilos AE, et al. Electroencephalogram signatures of ketamine-induced unconsciousness. Clin Neurophysiol. 2016;127(6):2414\u201322. https:\/\/doi.org\/10.1016\/j.clinph.2016.03.005.","journal-title":"Clin Neurophysiol"},{"key":"1859_CR13","first-page":"141","volume":"5","author":"L Coles","year":"2023","unstructured":"Coles L, Rosenthal ES, Bleck TP, et al. Why Ketamine. Epilepsy Behav. 2023;5:141.","journal-title":"Epilepsy Behav"},{"issue":"12","key":"1859_CR14","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1212\/WNL.0000000000200889","volume":"99","author":"M Jacobwitz","year":"2022","unstructured":"Jacobwitz M, Mulvihill C, Kaufman MC, et al. Ketamine for management of neonatal and pediatric refractory status epilepticus. Neurology. 2022;99(12):6.","journal-title":"Neurology"},{"issue":"1","key":"1859_CR15","doi-asserted-by":"publisher","first-page":"48","DOI":"10.5698\/1535-7597-16.1.48","volume":"16","author":"T Glauser","year":"2016","unstructured":"Glauser T, Shinnar S, Gloss D, et al. Evidence-based guideline: Treatment of convulsive status epilepticus in children and adults: report of the guideline committee of the American epilepsy society. Epilepsy Curr. 2016;16(1):48\u201361. https:\/\/doi.org\/10.5698\/1535-7597-16.1.48.","journal-title":"Epilepsy Curr"},{"issue":"1","key":"1859_CR16","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s12028-012-9695-z","volume":"17","author":"GM Brophy","year":"2012","unstructured":"Brophy GM, Bell R, Claassen J, et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care. 2012;17(1):3\u201323. https:\/\/doi.org\/10.1007\/s12028-012-9695-z.","journal-title":"Neurocrit Care"},{"key":"1859_CR17","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1111\/epi.17550","volume":"64","author":"S Buratti","year":"2023","unstructured":"Buratti S, Giacheri E, Palmieri A, et al. Ketamine as advanced second-line treatment in benzodiazepine-refractory convulsive status epilepticus in children. Epilepsia. 2023;64:797\u2013810. https:\/\/doi.org\/10.1111\/epi.17550.","journal-title":"Epilepsia"},{"issue":"2","key":"1859_CR18","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1097\/WNP.0000000000000165","volume":"32","author":"ST Herman","year":"2015","unstructured":"Herman ST, Abend NS, Bleck TP, et al. Consensus statement on continuous EEG in critically Ill adults and children, Part II: personnel, technical specifications, and clinical practice. J Clin Neurophysiol. 2015;32(2):96\u2013108. https:\/\/doi.org\/10.1097\/WNP.0000000000000165.","journal-title":"J Clin Neurophysiol"},{"issue":"2","key":"1859_CR19","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)-A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381. https:\/\/doi.org\/10.1016\/j.jbi.2008.08.010.","journal-title":"J Biomed Inform"},{"issue":"5","key":"1859_CR20","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1097\/WNP.0000000000000639","volume":"37","author":"S Witzman","year":"2020","unstructured":"Witzman S, Massey SL, Kessler S, et al. Acceptability of standardized EEG reporting in an electronic health record. J Clin Neurophysiol. 2020;37(5):455\u201361. https:\/\/doi.org\/10.1097\/WNP.0000000000000639.","journal-title":"J Clin Neurophysiol"},{"issue":"1","key":"1859_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/WNP.0b013e3182784729","volume":"30","author":"LJ Hirsch","year":"2013","unstructured":"Hirsch LJ, LaRoche SM, Gaspard N, et al. American Clinical Neurophysiology Society\u2019s standardized critical care EEG terminology: 2012 version. J Clin Neurophysiol. 2013;30(1):1\u201327.","journal-title":"J Clin Neurophysiol"},{"key":"1859_CR22","unstructured":"NINDS Common Data Elements Detailed Report for Adverse Events. https:\/\/www.commondataelements.ninds.nih.gov\/cde_detailed_report\/22914\/Adverse Events\/Safety Data\/content\/welcome. Accessed 1 May 2023"},{"key":"1859_CR23","unstructured":"U.S. Department of Health and Human Services. Common Terminology Criteria for Adverse Events (CTCAE).; 2017. https:\/\/ctep.cancer.gov\/protocoldevelopment\/electronic_applications\/docs\/CTCAE_v5_Quick_Reference_8.5x11.pdf"},{"issue":"10","key":"1859_CR24","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1053\/j.gastro.2016.08.014.CagY","volume":"60","author":"FW Fung","year":"2019","unstructured":"Fung FW, Jacobwitz M, Vala L, et al. Electroencephalographic seizures in critically Ill children: management and adverse effects. Epilepsia. 2019;60(10):2095\u2013104. https:\/\/doi.org\/10.1053\/j.gastro.2016.08.014.CagY.","journal-title":"Epilepsia"},{"issue":"3","key":"1859_CR25","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1097\/CCM.0b013e3182a66b76.Cornell","volume":"42","author":"C Traube","year":"2014","unstructured":"Traube C, Silver G, Kearney J, et al. Cornell assessment of pediatric delirium: a valid, rapid, observational tool for screening delirium in the PICU*. Crit Care Med. 2014;42(3):656\u201363. https:\/\/doi.org\/10.1097\/CCM.0b013e3182a66b76.Cornell.","journal-title":"Crit Care Med"},{"issue":"6","key":"1859_CR26","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1097\/PCC.0b013e31818c8328.The","volume":"9","author":"LS Franck","year":"2008","unstructured":"Franck LS, Harris SK, Soetenga DJ, Amling JK, Curley MAQ. The withdrawal assessment tool-version 1 (WAT-1): an assessment instrument for monitoring opioid and benzodiazepine withdrawal symptoms in pediatric patients. Pediatr Crit Care Med. 2008;9(6):573\u201380. https:\/\/doi.org\/10.1097\/PCC.0b013e31818c8328.The.","journal-title":"Pediatr Crit Care Med"},{"key":"1859_CR27","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1007\/s40263-018-0569-6","volume":"32","author":"A Rosati","year":"2018","unstructured":"Rosati A, De Masi S, Guerrini R. Ketamine for refractory status epilepticus: a systematic review. CNS Drugs. 2018;32:997\u20131009.","journal-title":"CNS Drugs"},{"key":"1859_CR28","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.pediatrneurol.2019.09.003","volume":"103","author":"RJ Huntsman","year":"2020","unstructured":"Huntsman RJ, Strueby L, Bingham W. Are ketamine infusions a viable therapeutic option for refractory neonatal seizures? Pediatr Neurol. 2020;103:8\u201311.","journal-title":"Pediatr Neurol"},{"issue":"4","key":"1859_CR29","first-page":"295","volume":"58","author":"J Wu","year":"2020","unstructured":"Wu J, Wang Q, Qian SY, et al. Effectiveness of ketamine in the treatment of refractory and super-refractory status epilepticus in children. Chin J Pediatr. 2020;58(4):295\u2013300.","journal-title":"Chin J Pediatr"},{"issue":"6","key":"1859_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/bmjopen-2016-011565","volume":"6","author":"A Rosati","year":"2016","unstructured":"Rosati A, Ilvento L, L\u2019Erario M, et al. Efficacy of ketamine in refractory convulsive status epilepticus in children: a protocol for a sequential design, multicentre, randomised, controlled, open-label, non-profit trial (KETASER01). BMJ Open. 2016;6(6):1\u20136. https:\/\/doi.org\/10.1136\/bmjopen-2016-011565.","journal-title":"BMJ Open"},{"issue":"5","key":"1859_CR31","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1177\/0310057X1804600514","volume":"46","author":"D Golub","year":"2018","unstructured":"Golub D, Yanai A, Darzi K, Papadopoulos J, Kaufman B. Potential consequences of high-dose infusion of ketamine for refractory status epilepticus: case reports and systematic literature review. Anaesth Intensive Care. 2018;46(5):516\u201328. https:\/\/doi.org\/10.1177\/0310057X1804600514.","journal-title":"Anaesth Intensive Care"},{"issue":"August","key":"1859_CR32","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/epi.14480","volume":"59","author":"J H\u00f6fler","year":"2018","unstructured":"H\u00f6fler J, Trinka E. Intravenous ketamine in status epilepticus. Epilepsia. 2018;59(August):198\u2013206. https:\/\/doi.org\/10.1111\/epi.14480.","journal-title":"Epilepsia"},{"key":"1859_CR33","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.yebeh.2015.06.019","volume":"49","author":"L Ilvento","year":"2015","unstructured":"Ilvento L, Rosati A, Marini C, L\u2019Erario M, Mirabile L, Guerrini R. Ketamine in refractory convulsive status epilepticus in children avoids endotracheal intubation. Epilepsy Behav. 2015;49:343\u20136.","journal-title":"Epilepsy Behav"},{"issue":"24","key":"1859_CR34","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1212\/WNL.0b013e318278b685","volume":"79","author":"A Rosati","year":"2012","unstructured":"Rosati A, L\u2019Erario M, Ilvento L, et al. Efficacy and safety of ketamine in refractory status epilepticus in children. Neurology. 2012;79(24):2355\u20138. https:\/\/doi.org\/10.1212\/WNL.0b013e318278b685.","journal-title":"Neurology"},{"issue":"8","key":"1859_CR35","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1111\/epi.12247.Intravenous","volume":"54","author":"N Gaspard","year":"2013","unstructured":"Gaspard N, Foreman B, Judd LM, et al. Intravenous ketamine for the treatment of refractory status epilepticus: a retrospective multi-center study. Epilepsia. 2013;54(8):1498\u2013503. https:\/\/doi.org\/10.1111\/epi.12247.Intravenous.","journal-title":"Epilepsia"},{"issue":"12","key":"1859_CR36","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1007\/s00134-006-0362-8","volume":"32","author":"G Morrison","year":"2006","unstructured":"Morrison G, Gibbons E, Whitehouse WP. High-dose midazolam therapy for refractory status epilepticus in children. Intensive Care Med. 2006;32(12):2070\u20136. https:\/\/doi.org\/10.1007\/s00134-006-0362-8.","journal-title":"Intensive Care Med"},{"issue":"1","key":"1859_CR37","first-page":"37","volume":"35","author":"JL Blumer","year":"1998","unstructured":"Blumer JL. Clinical pharmacology of Midazolam in infants and children. Science. 1998;35(1):37\u201347.","journal-title":"Science"},{"issue":"1","key":"1859_CR38","doi-asserted-by":"publisher","first-page":"73","DOI":"10.5863\/1551-6776-26.1.73","volume":"26","author":"F Sperotto","year":"2021","unstructured":"Sperotto F, Giaretta I, Mondardini MC, Pece F, Daverio M, Amigoni A. Ketamine prolonged infusions in the pediatric intensive care unit: a tertiary-care single-center analysis. J Pediatr Pharmacol Ther. 2021;26(1):73\u201380. https:\/\/doi.org\/10.5863\/1551-6776-26.1.73.","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"16","key":"1859_CR39","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1212\/WNL.0000000000010611","volume":"95","author":"A Alkhachroum","year":"2020","unstructured":"Alkhachroum A, Der-Nigoghossian CA, Mathews E, et al. Ketamine to treat super-refractory status epilepticus. Neurology. 2020;95(16):69.","journal-title":"Neurology"},{"issue":"12","key":"1859_CR40","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.1111\/epi.17068","volume":"62","author":"FW Fung","year":"2021","unstructured":"Fung FW, Parikh DS, Massey SL, et al. Periodic and rhythmic patterns in critically ill children: incidence, interrater agreement, and seizures. Epilepsia. 2021;62(12):2955\u201367. https:\/\/doi.org\/10.1111\/epi.17068.","journal-title":"Epilepsia"},{"issue":"1","key":"1859_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/WNP.0000000000000806","volume":"38","author":"LJ Hirsch","year":"2021","unstructured":"Hirsch LJ, Fong MWK, Leitinger M, et al. American Clinical Neurophysiology Society\u2019s standardized critical Care EEG terminology: 2021 version. J Clin Neurophysiol. 2021;38(1):1\u201329.","journal-title":"J Clin Neurophysiol"}],"container-title":["Neurocritical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-023-01859-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12028-023-01859-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12028-023-01859-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T22:05:34Z","timestamp":1717452334000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12028-023-01859-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,2]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["1859"],"URL":"https:\/\/doi.org\/10.1007\/s12028-023-01859-2","relation":{},"ISSN":["1541-6933","1556-0961"],"issn-type":[{"value":"1541-6933","type":"print"},{"value":"1556-0961","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,2]]},"assertion":[{"value":"7 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no conflicts of interest to disclose.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This article adheres to ethical guidelines and was approved by the institutional review board with a waiver of consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval\/Informed Consent"}}]}}